跳至主要内容
临床试验/CTRI/2020/04/024945
CTRI/2020/04/024945已完成未知

Effects of tamsulosin and tamsulosin + solifenacin combination therapy in treatment of ureteral stent related lower urinary tract symptoms.

ankit0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients undergoing Double-J stenting for ureteral intervention were included in the study.

排除标准

  • 1-Patients who were previously diagnosed with benign prostatic hyperplasia or overactive bladder.
  • 2-Pregnant women.
  • 3- Psychiatric illness
  • 4-Urinary tract infections.
  • 5-Previous use of selective alpha-1- blocker and or antimuscarinic agent or with known history of orthostatic hypotension,allergy,hypersensitivity to one or more alpha blockers.
  • 6-Patients under ICU management
  • 7-Patients on dialysis.

研究者

发起方
ankit

相似试验